Shailaja Chidella, MD
Nephrology · Lawrenceville, GANPI 1376786871
Payments from drug & device makers
Across 86 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$314
- AstraZeneca$206
- Otsuka America Pharmaceutical, Inc.$197
- Bayer$143
- Vifor Pharma, Inc.$126
- Novartis$104
- plus $604 from 12 others
What the payments were for
- Food & beverage$1,63596%
- Education$614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 16 | $314 |
| AstraZeneca(2 entities) | 11 | $206 |
| Otsuka America Pharmaceutical, Inc. | 7 | $197 |
| Bayer | 7 | $143 |
| Vifor Pharma, Inc. | 5 | $126 |
| Novartis | 7 | $104 |
| OPKO Pharmaceuticals, LLC | 5 | $98 |
| Aurinia Pharma U.S., Inc. | 6 | $97 |
| Sanofi | 3 | $87 |
| GSK | 5 | $71 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Calliditas Therapeutics US Inc. | 3 | $53 |
| Travere Therapeutics, Inc. | 2 | $31 |
| Apellis Pharmaceuticals, Inc. | 2 | $30 |
| Leadiant Biosciences, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,696 in reported general payments places this provider in the 45th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Torsemide | 36 | $716 |
| Doxazosin Mesylate | 12 | $301 |
| Calcitriol | 41 | $238 |
| Allopurinol | 33 | $212 |
| Lisinopril | 16 | $125 |
| Amlodipine Besylate | 21 | $116 |
| Tamsulosin Hcl | 13 | $114 |
| Carvedilol | 23 | $87 |
| Furosemide | 20 | $84 |
| Gabapentin | 11 | $74 |
| Losartan Potassium | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Lawrenceville
- James TumlinLawrenceville$19.8M
- Kirti ShahLawrenceville$266K
- Ayorinde SoipeLawrenceville$218K
- William PaxtonLawrenceville$85K
- Lorin SanchezLawrenceville$76K
- Sharad VirmaniLawrenceville$55K
- Aakash AminLawrenceville$22K
- Chinedu NwekeAcworth$3.9M
- Vinayak RamanathLagrange$3.1M
- Harold HubertAugusta$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.